RHOGEN

Our team at Rhogen is formed by highly qualified scientists and strategists in the field of developing state of the art predictive models for early diagnosis of sepsis and innovative therapies in addressing the growing needs of the sepsis. In addition, our team relies on a network of knowledge through the advisory board in the medical research and technology, along with successful, commercial, and entrepreneurial experiences... At Rhogen, we have developed a roadmap to achieve the desired outcome of innovative therapy to treat the Sepsis. Our illustrative roadmap with an eye towards bringing innovative therapeutic options for the treatment of life-threatening organ dysfunction to the market... We focus our efforts on the importance and the need for developing successful drug-diagnostic co-development models and bringing us closer towards a more promising future for pharmacotherapy and patient care in treating life-threatening organ dysfunction - Sepsis. We dedicate our efforts around..

Also known as: Rhogen Biotech